CSPC Innovation Pharmaceutical Co., Ltd. (SHE:300765)
China
· Delayed Price · Currency is CNY 30.67
-0.31 (-1.00%)
At close: Dec 5, 2025
SHE:300765 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 42,711 | 37,029 | 42,873 | 9,767 | 8,376 | 7,858 | Upgrade
|
| Market Cap Growth | 12.34% | -13.63% | 338.97% | 16.61% | 6.59% | 10.06% | Upgrade
|
| Enterprise Value | 41,955 | 36,671 | 39,717 | 7,864 | 6,725 | 6,463 | Upgrade
|
| Last Close Price | 30.67 | 26.58 | 30.25 | 7.19 | 6.92 | 6.45 | Upgrade
|
| PE Ratio | - | 689.22 | 98.69 | 13.45 | 21.30 | 26.21 | Upgrade
|
| PS Ratio | 20.39 | 18.69 | 16.89 | 3.72 | 4.53 | 5.97 | Upgrade
|
| PB Ratio | 10.26 | 8.24 | 7.82 | 2.48 | 2.54 | 2.93 | Upgrade
|
| P/TBV Ratio | 12.32 | 10.56 | 8.49 | 2.51 | 2.59 | 3.00 | Upgrade
|
| P/FCF Ratio | - | - | 306.85 | 18.54 | 86.64 | 33.97 | Upgrade
|
| P/OCF Ratio | - | - | 59.45 | 15.24 | 28.68 | 22.51 | Upgrade
|
| EV/Sales Ratio | 20.03 | 18.51 | 15.64 | 2.99 | 3.64 | 4.91 | Upgrade
|
| EV/EBITDA Ratio | - | - | 128.72 | 9.60 | 13.34 | 16.26 | Upgrade
|
| EV/EBIT Ratio | - | - | 258.24 | 10.53 | 15.46 | 18.78 | Upgrade
|
| EV/FCF Ratio | -58.25 | - | 284.26 | 14.93 | 69.57 | 27.94 | Upgrade
|
| Debt / Equity Ratio | 0 | 0 | 0 | 0.01 | 0 | - | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.01 | 0.02 | 0.00 | - | Upgrade
|
| Debt / FCF Ratio | - | - | 0.01 | 0.04 | 0.01 | - | Upgrade
|
| Asset Turnover | 0.35 | 0.29 | 0.42 | 0.63 | 0.55 | 0.45 | Upgrade
|
| Inventory Turnover | 3.27 | 3.71 | 5.98 | 5.97 | 5.59 | 4.97 | Upgrade
|
| Quick Ratio | 1.01 | 1.58 | 2.28 | 5.00 | 5.31 | 7.54 | Upgrade
|
| Current Ratio | 1.54 | 1.95 | 2.42 | 5.48 | 6.09 | 8.17 | Upgrade
|
| Return on Equity (ROE) | -12.72% | -6.08% | 2.67% | 20.07% | 13.12% | 11.75% | Upgrade
|
| Return on Assets (ROA) | -6.48% | -2.56% | 1.59% | 11.22% | 8.12% | 7.41% | Upgrade
|
| Return on Capital (ROIC) | -8.67% | -3.46% | 2.03% | 12.86% | 9.08% | 8.43% | Upgrade
|
| Return on Capital Employed (ROCE) | -14.30% | -6.00% | 2.80% | 18.70% | 13.00% | 12.60% | Upgrade
|
| Earnings Yield | -0.26% | 0.14% | 1.01% | 7.44% | 4.70% | 3.82% | Upgrade
|
| FCF Yield | -1.69% | -4.63% | 0.33% | 5.39% | 1.15% | 2.94% | Upgrade
|
| Dividend Yield | 0.07% | 0.07% | 0.88% | 0.97% | 1.00% | 0.55% | Upgrade
|
| Payout Ratio | - | 696.42% | 22.52% | 11.30% | 10.68% | 9.34% | Upgrade
|
| Buyback Yield / Dilution | 0.71% | -0.16% | -4.50% | 0.02% | -13.53% | -6.56% | Upgrade
|
| Total Shareholder Return | 0.77% | -0.08% | -3.62% | 0.98% | -12.53% | -6.01% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.